AVORO CAPITAL ADVISORS LLC 13D and 13G filings for Acceleron Pharma Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
2021-11-24 3:48 pm Sale |
2021-11-22 | 13D | Acceleron Pharma Inc. XLRN |
AVORO CAPITAL ADVISORS LLC | 0 0.000% |
-4,476,100![]() (Position Closed) |
Filing |
2021-10-05 12:30 pm Purchase |
2021-09-30 | 13D | Acceleron Pharma Inc. XLRN |
AVORO CAPITAL ADVISORS LLC | 4,476,100 7.300% |
4,476,100![]() (New Position) |
Filing |